New LNPs crossed the blood-brain barrier in primates and cut stroke damage in rats

Key Findings

🧬 A Blood Test That Compares Six Nanoparticles at Once — In Primates

• A new method called non-invasive nanoparticle barcoding lets researchers measure functional mRNA delivery from six different LNP formulations in a single nonhuman primate using just 30 microliters of blood — no euthanasia, no complex tissue processing.
• The trick is DNA barcodes that covalently attach to a protein encoded by the mRNA inside the cell, then get exported into the bloodstream where they can be sequenced. It also revealed meaningful differences in how LNPs perform between mice and primates.

💉 An Enzyme That Makes Subcutaneous mRNA Shots Work Like IV Infusions

• Co-administering rHuPH20 — an enzyme that temporarily loosens the tissue matrix under the skin — boosted whole-body mRNA expression up to 38-fold after subcutaneous injection in mice, and pushed protein exposure from a subcutaneous shot close to intravenous benchmarks in minipigs.
• The enzyme worked across different ionizable lipid formulations and was also associated with lower inflammatory cytokine responses after repeat dosing, not higher ones.

🫁 The Route Into the Lung Changes Everything for Tumor Immunity

• Intratracheal delivery of mRNA-LNP cancer vaccines produced only 2.6-fold more total lung protein expression than intranasal delivery — but 26.8-fold more functional transfection specifically inside alveolar macrophages, the dominant antigen-presenting cells in the lung.
• When researchers depleted alveolar macrophages, the antitumor protection from intratracheal vaccination disappeared entirely, confirming these cells as the essential mechanism rather than a side effect.

🌿 Vitamin-Derived Lipids Outperform Commercial Delivery Systems in Vaccine Models

• A screen of eight vitamin-conjugated ionizable lipids found two that produced higher in vivo protein expression than a commercial LNP control, with better stability and a cleaner safety profile in animal studies.
• When used to deliver varicella-zoster and respiratory syncytial virus mRNAs, these vitamin-lipid LNPs induced stronger immune responses at lower doses than the commercial benchmark — no obvious toxicity or adverse reactions observed.

🤖 AI Tripled the Training Data and Predicted Better Lipid Hits

• A machine learning framework called LipidAI used a 'methyl tail augmentation' strategy — precisely adjusting methyl groups on lipid tail chains — to triple the available training data from existing ionizable lipid libraries, compensating for the small dataset problem that has plagued AI approaches in this field.
• Predictions from the ensemble model aligned closely with actual in vivo mRNA expression results, suggesting the framework can meaningfully reduce the experimental burden of lipid screening.

⚠️ Codon Optimization Creates a Hidden Translation Problem in mRNA Drugs

• Standard codon optimization — used in nearly every mRNA therapeutic including COVID-19 vaccines — systematically depletes stop codons in alternative reading frames, because optimal human codons exclude uridine from third positions and all three stop codons start with uridine.
• Analysis of 120 therapeutic sequences found that out-of-frame protein products average 164 amino acids in codon-optimized sequences, six times longer than in natural human genes. Strategic synonymous substitutions eliminated detectable out-of-frame products by mass spectrometry without changing the intended protein.